Search research articles
Contact Us
Filters
Showing results (651-660 of 764) with videos related to
Page
of 77
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma
R S Freedman, J A Gibbons, M Giedlin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2009
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
I Vergote, N Finkler, J del Campo, et al.
Cancer
|
May 1, 1986
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin
D M Gershenson, J J Kavanagh, L J Copeland, et al.
Cancer Biology & Therapy
|
August 17, 2012
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3
Siqing Fu, Yanfang Li, Jie Huang, et al.
Journal of Immunological Methods
|
August 23, 2001
Simultaneous analysis of surface marker expression and cell cycle progression in human peripheral blood mononuclear cells
M T Rosato, A J Jabbour, R A Ponce, et al.
Molecular Pharmacology
|
October 20, 2001
Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2
M L Adams, R H Pierce, M E Vail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma
C F Verschraegen, T Sittisomwong, A P Kudelka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 27, 2005
Profiling of differentially expressed genes in human uterine leiomyomas
E-J Lee, G Kong, S-H Lee, et al.
Pigment Cell Research
|
July 11, 2006
Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes
Jennifer E Hauser, Ana Luisa Kadekaro, Renny J Kavanagh, et al.
Anti-Cancer Drugs
|
March 10, 1998
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor
C F Verschraegen, E A Natelson, B C Giovanella, et al.
Page
of 77
Search research articles
Search
Showing results (651-660 of 764) with videos related to
Sort By:
Page
of 77
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy
|
November 1, 1996
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma
R S Freedman, J A Gibbons, M Giedlin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 12, 2009
Phase 3 randomised study of canfosfamide (Telcyta, TLK286) versus pegylated liposomal doxorubicin or topotecan as third-line therapy in patients with platinum-refractory or -resistant ovarian cancer
I Vergote, N Finkler, J del Campo, et al.
Cancer
|
May 1, 1986
Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatin
D M Gershenson, J J Kavanagh, L J Copeland, et al.
Cancer Biology & Therapy
|
August 17, 2012
Aurora kinase inhibitor VE 465 synergistically enhances cytotoxicity of carboplatin in ovarian cancer cells through induction of apoptosis and downregulation of histone 3
Siqing Fu, Yanfang Li, Jie Huang, et al.
Journal of Immunological Methods
|
August 23, 2001
Simultaneous analysis of surface marker expression and cell cycle progression in human peripheral blood mononuclear cells
M T Rosato, A J Jabbour, R A Ponce, et al.
Molecular Pharmacology
|
October 20, 2001
Enhanced acetaminophen hepatotoxicity in transgenic mice overexpressing BCL-2
M L Adams, R H Pierce, M E Vail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 15, 2000
Docetaxel for patients with paclitaxel-resistant Müllerian carcinoma
C F Verschraegen, T Sittisomwong, A P Kudelka, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 27, 2005
Profiling of differentially expressed genes in human uterine leiomyomas
E-J Lee, G Kong, S-H Lee, et al.
Pigment Cell Research
|
July 11, 2006
Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes
Jennifer E Hauser, Ana Luisa Kadekaro, Renny J Kavanagh, et al.
Anti-Cancer Drugs
|
March 10, 1998
A phase I clinical and pharmacological study of oral 9-nitrocamptothecin, a novel water-insoluble topoisomerase I inhibitor
C F Verschraegen, E A Natelson, B C Giovanella, et al.
Page
of 77